AI
VERA icon

Atom Investors’s Vera Therapeutics VERA Stock Holding History

Atom Investors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,539
Closed -$655K – 816
2025
Q3 		$655K Buy
22,539
+8,750
+63% +$202K 0.05% 318
2025
Q2 		$325K Buy
+13,789
New +$310K 0.03% 425

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Atom Investors's VERA Position: Q4 2025 in Review

Atom Investors sold out of Vera Therapeutics (VERA) in Q4 2025, closing a stake of 22,539 shares — an estimated $655K sold.

Atom Investors first reported a position in VERA in Q2 2025 and held it in 2 quarters. The position peaked at $655K in Q3 2025. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

  • Atom Investors reported no remaining Vera Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Atom Investors sold 22,539 Vera Therapeutics shares in Q4 2025, an estimated $655K.
  • Atom Investors first reported a position in Vera Therapeutics in Q2 2025 and held it in 2 quarters.
  • Atom Investors's Vera Therapeutics position peaked at $655K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on Atom Investors's 13F filing for Q4 2025, filed 17 Feb 2026.